YOU ARE HERE : Endocrinology and Diabetes / : Faculty : Niyaz Gosmanov, MD - Assistant Professor
Section Home
  A-Z list, faculty & staff
  Adjunct Faculty
  Clinical Fellows
  Clinical Staff
  Research Fellows / Post Docs
  Research Staff
  Graduate Students
  Administrative Staff
  Endocrinology Event Calendar
  Clinical Fellowship Program
  Research Programs
  Weekly Seminars
  Annual Meetings
  Program Grants
Harold Hamm Diabetes Center
Positions Available
Visit Oklahoma City
Visit Tulsa
Cost of Living Comparison
Niyaz Gosmanov, MD, CDE
Associate Professor
Certified Diabetes Educator
Mailing Address:
VA Hospital
921 NE 13th Street, 5A-156
Oklahoma City, OK 73104
(405) 456-3368
(405) 456-5934

Research Interests

  1. Use of insulin-glucose clamps to measure insulin sensitivity, insulin secretion rates, and counter-regulatory hormone responses.
  2. Application of human study techniques (including use of radioactive isotopes, indirect calorimetry, and bioimpedance) for assessment of physiological responses to eating. Studies using these methods to assess efficacy of medications used in diabetes mellitus.
  3. Evaluation of efficacy and economic impact of Home TeleHealth modality (utilizing “HealthBuddy” monitor) in management of common chronic disease models with main focus on Diabetes Mellitus and Obesity.


2001-2004 Clinical Fellow - Dept of Medicine/Endocrinology Section, University of Rochester, Rochester, NY
1998-2001 Internal Medicine Residency Program, Unity Health System, Rochester, NY
1994-1996 Internal Medicine Residency, Kazan State Medical University, Kazan, Russia
1986-1994 MD - Kazan State Medical University, Kazan Russia

Recent Publications

Gosmanov AR, Connelly S, Lewis JB Jr, Gosmanov NR. Antihypertensive medications and the risk of incident type 2 diabetes: response to Taylor et al. Diabetes Care. 2006 Oct;29(10): 2334; author reply 2334-5.

Szoke, Gosmanov NR, Sinkin JC, Nihalani A, Fender AB, Cryer PE, Meyer C, Gerich JE. Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia. Metabolism 55:78-83, 2006.

Woerle HJ, Szoke E, Meyer C, Dostou JM, Wittlin SD, Gosmanov NR, Welle SL, Gerich JE. Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes. Am J Physiol Endocrinol Metab. 290:E67-E77, 2006.

Israelian Z, Gosmanov NR, Szoke E, Schorr M, Bokhari S, Cryer PE, Gerich JE and Meyer C.  Increasing the decrement in insulin secretion improves glucagon responses to hypoglycemia in advanced type 2 diabetes. Diabetes Care 28:2691-6, 2005.

Gosmanov NR, Szoke E, Israelian Z, Smith T, Cryer PE, Gerich JE and Meyer C.  Role of the decrement in intraislet insulin for the glucagon response to hypoglycemia in humans. Diabetes Care 28:1124-31, 2005.

Pham T, Scofield H, Gosmanov NR. "Metabolic Consequences of Oral Glucosamine Supplement Intake in Non-Diabetic Adults" Abstract. American Diabetes Association, 65th Scientific Sessions. June 10-14, 2005, San Diego, CA. Diabetes, in Press, 2005.

Reviews and Invited Papers

Gosmanov NR,“Your Diabetes Health Care Team” Quarterly Newsletter in OKC VAMC Winter 2005-06.

Books Chapters and Manuscripts

Gerich J, Gosmanov NR: Pathogenesis of type 2 diabetes. Chapter in "Atlas of Diabetes". Skyler J, 2nd Edition. New York: Lippincott Williams & Wilkins, 2002, pp. 71-82.

TOP ^  
The University of Oklahoma Health Sciences Center

Endocrinology and Diabetes
1000 N. Lincoln Blvd.; Harold Hamm Diabetes Center Building #2900
Oklahoma City, OK 73104
Phone - (405) 271-5896
FAX - (405) 271-7522

Every effort will be made to update the information contained on these pages as necessary. However, it is the responsibility ofthe user to determine that he or she is relying on the most current version of any particular information. Any questions about the material should be directed to the referenced office or department.